Antibody Drug Conjugates Market Systematic Review Future Scope 2032
Market Scope:
In the ever-evolving landscape of cancer therapy, Antibody Drug Conjugates (ADCs) have emerged as a promising frontier. These groundbreaking treatments combine the precision of monoclonal antibodies with the potency of cytotoxic drugs, offering a new ray of hope for patients battling cancer. In this article, we will delve into the scope of the Antibody Drug Conjugates market, exploring its potential, challenges, and future prospects.